| Q38190426 | 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up |
| Q58757348 | A Systematic Literature Review on Salvage Radiotherapy for Local or Regional Recurrence After Previous Stereotactic Body Radiotherapy for Lung Cancer |
| Q36241457 | Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer |
| Q46037366 | Cons: After lung stereotactic ablative radiotherapy for a peripheral stage I non-small cell lung carcinoma, radiological suspicion of a local recurrence is not sufficient indication to proceed to salvage therapy. |
| Q37073674 | Current Topics on Salvage Thoracic Surgery in Patients with Primary Lung Cancer |
| Q45070442 | Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings |
| Q45729506 | Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes |
| Q38577289 | Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival? |
| Q64997326 | Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age. |
| Q42348006 | Lobectomy: no port at all? |
| Q84632256 | Lung-cancer related chest events detected by periodical follow-up CT after stereotactic body radiotherapy for stage I primary lung cancer: retrospective analysis of incidence of lung-cancer related chest events and outcomes of salvage treatment |
| Q33824712 | Management of mediastinal relapse after treatment with stereotactic body radiotherapy or accelerated hypofractionated radiotherapy for stage I/II non-small-cell lung cancer |
| Q38849150 | Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? |
| Q89967161 | Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study |
| Q41281860 | Risk for surgical complications after previous stereotactic body radiotherapy of the spine |
| Q59792187 | Salvage Pulmonary Operations Following Stereotactic Body Radiotherapy for Small Primary and Metastatic Lung Tumors: Evaluation of the Operative Procedures |
| Q39265624 | Salvage surgery after high-dose radiotherapy |
| Q37307675 | Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer |
| Q63367919 | Salvage surgery for local recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: a systematic review |
| Q89795680 | Salvage video-assisted thoracoscopic lobectomy for isolated local relapse after stereotactic body radiotherapy for early stage non-small cell lung cancer: technical aspects and perioperative management |
| Q38161371 | Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team |
| Q38994894 | Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC). |
| Q36476122 | Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer? |
| Q35667829 | Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies |
| Q61804652 | Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy |
| Q35113011 | The role of stereotactic ablative radiotherapy for early-stage and oligometastatic non-small cell lung cancer: evidence for changing paradigms |
| Q37735284 | Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment |
| Q26853124 | Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy? |
| Q38110978 | Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy? |